Avantages cardiovasculaires et mtaboliques Le smaglutide, comme l'a dmontr l'tude SELECT, a tabli des bnfices cardiovasculaires long terme, avec une perte de poids moyenne de 10.2 % sur quatre ans, soulignant son rle dans la rduction des risques cardiomtaboliques
I dati topline, comunicati da Lilly nel dicembre 2025 e in attesa di pubblicazione peer-reviewed, mostrano che lendpoint primario stato raggiunto
Burks TN, Andres-Mateos E, Marx R, Mejias R, Van Erp C, Simmers JL, Walston JD, Ward CW, Cohn RD (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia
Simmons shares her personal journey, highlighting her family's history with breast cancer and her own diagnosis, which prompted her to question conventional treatments
It mimics the naturally occurring hormone GLP-1 to suppress your appetite, tell your brain that youre full, and slow down the digestive process